Published in Dev Biol Stand on January 01, 1995
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
Phase and antigenic variation in bacteria. Clin Microbiol Rev (2004) 5.02
A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol (1999) 3.81
Role of mga in growth phase regulation of virulence genes of the group A streptococcus. J Bacteriol (1997) 2.20
Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. Infect Immun (2001) 1.34
Regulation of mga transcription in the group A streptococcus: specific binding of mga within its own promoter and evidence for a negative regulator. J Bacteriol (1999) 1.23
Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice. Infect Immun (2001) 0.81
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol (1987) 2.54
Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A (1994) 2.39
Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38
Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem (1990) 2.31
Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis. J Immunol (1982) 2.27
Physical characterization of ten R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections. Antimicrob Agents Chemother (1979) 2.21
Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol (1990) 2.16
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Insertional inactivation of streptolysin S expression in Streptococcus pyogenes. J Bacteriol (1983) 2.13
Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants. J Med Microbiol (1977) 2.12
Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49. J Bacteriol (1989) 2.04
DNA fingerprinting of Streptococcus zooepidemicus (Lancefield group C) as an aid to epidemiological study. J Infect Dis (1987) 1.99
Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci U S A (1989) 1.97
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis (1987) 1.88
Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol (1988) 1.83
Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis (1989) 1.75
Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun (1998) 1.70
Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun (1983) 1.70
Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol Microbiol (1993) 1.66
Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein. Infect Immun (1987) 1.66
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect Immun (1997) 1.60
Deletion and complementation analysis of biotin gene cluster of Escherichia coli. J Bacteriol (1972) 1.57
Characterization of prototype and clinically defined strains of Streptococcus suis by genomic fingerprinting. J Clin Microbiol (1990) 1.56
Location of promoter and operator sites in the biotin gene cluster of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.55
Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun (1996) 1.51
Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog (1987) 1.51
High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol (1999) 1.48
Genetic instability of M protein and serum opacity factor of group A streptocci: evidence suggesting extrachromosomal control. Infect Immun (1975) 1.44
VirR and Mry are homologous trans-acting regulators of M protein and C5a peptidase expression in group A streptococci. Mol Gen Genet (1993) 1.39
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol (1985) 1.37
Identification of epidemic strains of Streptococcus suis by genomic fingerprinting. J Clin Microbiol (1991) 1.36
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med (1996) 1.34
A DNA substitution in the group A streptococcal bacteriophage SP24. Virology (1983) 1.34
Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci. Infect Immun (1992) 1.32
Bacteriophage control of antiphagocytic determinants in group A streptococci. J Exp Med (1980) 1.25
Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus. Infect Immun (1987) 1.25
Plasmid macroevolution in a nosocomial environment: demonstration of a persistent molecular polymorphism and construction of a cladistic phylogeny on the basis of restriction data. Mol Gen Genet (1984) 1.24
Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol (1992) 1.22
Purification and characteristics of the streptococcal chemotactic factor inactivator. Infect Immun (1985) 1.22
Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of ScpA, FcRA, OF, and M protein. FEMS Microbiol Lett (1995) 1.18
Purification of the proteinase from group B streptococci that inactivates human C5a. Biochim Biophys Acta (1991) 1.17
Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis (1998) 1.16
Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect Immun (1986) 1.15
Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene. Infect Immun (1989) 1.15
Hospital distribution, persistence, and reintroduction of related gentamicin R plasmids. Antimicrob Agents Chemother (1986) 1.13
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein. J Immunol (1987) 1.13
Type M12 protein from Streptococcus pyogenes is a receptor for IgG3. J Immunol (1993) 1.11
Possible dual function of M protein: resistance to bacteriophage A25 and resistance to phagocytosis by human leukocytes. Infect Immun (1977) 1.08
Genetic dissection of the Streptococcus pyogenes M1 protein: regions involved in fibronectin binding and intracellular invasion. Microb Pathog (2001) 1.07
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. Proc Natl Acad Sci U S A (2000) 1.02
M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin. Infect Immun (1994) 1.02
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci. J Bacteriol (1979) 1.02
The human antibody response to streptococcal C5a peptidase. J Infect Dis (1991) 1.00
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Transcriptional control in the L-arabinose operon of Escherichia coli B-r. J Bacteriol (1974) 0.97
Enzymic reduction of d-biotin d-sulfoxide to d-biotin. Methods Enzymol (1979) 0.96
Retracted High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1997) 0.96
Community-wide outbreak of group G streptococcal pharyngitis. Pediatrics (1991) 0.95
More than one DNA sequence encodes the 2''-O-adenylyltransferase phenotype. Antimicrob Agents Chemother (1987) 0.92
Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate. J Bacteriol (2000) 0.91
Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination. Mol Gen Genet (1996) 0.90
A restriction map and analysis of the terminal redundancy in the group a streptococcal bacteriophage SP24. Virology (1983) 0.87
Intranasal bacteria induce Th1 but not Treg or Th2. Mucosal Immunol (2008) 0.87
Enzymatic reduction of D-biotin-d-sulfoxide with cell-free extracts of Escherichia coli. Biochem Biophys Res Commun (1974) 0.87
Genetic separation of serum opacity factor from M protein of group A streptococci. Infect Immun (1978) 0.86
Immunoglobulin-binding FcrA and Enn proteins and M proteins of group A streptococci evolved independently from a common ancestral protein. Med Microbiol Immunol (1994) 0.84
Streptococcus pyogenes type IIa IgG Fc receptor expression is co-ordinately regulated with M protein and streptococcal C5a peptidase. Mol Microbiol (1994) 0.84
Integration of bacteriophage SP24 into the chromosome of group A streptococci. J Bacteriol (1985) 0.81
Group A and group B streptococcal vaccine development. A round table presentation. Adv Exp Med Biol (1997) 0.79
High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1998) 0.77
Testing meningeal strains of Streptococcus suis to detect M protein genes. Res Vet Sci (1992) 0.76
Streptococcus pyogenes type M12 protein shows selective binding to some human immunoglobulin G3 myeloma proteins. Infect Immun (1994) 0.75